...
首页> 外文期刊>RSC Advances >Anti-microbial activity of chrysomycin A produced by Streptomyces sp. against Mycobacterium tuberculosis
【24h】

Anti-microbial activity of chrysomycin A produced by Streptomyces sp. against Mycobacterium tuberculosis

机译:链霉菌菌产生的Chrysomycin A的抗菌活性。对抗结核分枝杆菌

获取原文

摘要

Limited efficacy of the BCG (Bacillus Calmette–Guérin) vaccine against adult tuberculosis and the emergence of resistance to existing anti-tuberculosis drugs compel discovery of novel antibiotics against Mycobacterium tuberculosis. Actinomycetes are still an attractive platform for the discovery of new antimicrobials, especially from untapped natural hotspots, despite the belief that they are an exhausted resource after repeated re-discoveries. Herein we report the isolation and identification of chrysomycin A from an actinomycete isolated from a coastal area in Kerala. We show for the first time that it has antimycobacterial activity. It was found to be bactericidal to planktonic and intracellular M. tuberculosis with an MIC of 3.125 μg mL?1; it is non-hemolytic and has negligible cytotoxicity. The actinomycete that produces chrysomycin A was found to be a Streptomyces sp. through 16S rRNA gene sequencing.
机译:卡介苗(Bacillus Calmette–Guérin)疫苗对成人结核病的疗效有限,并且对现有抗结核药物的耐药性的出现迫使人们发现了针对结核分枝杆菌的新型抗生素。放线菌仍然是发现新的抗菌剂的有吸引力的平台,尤其是从尚未开发的天然热点中发现新的抗菌剂,尽管人们认为放线菌是经过反复重新发现后已经耗尽的资源。在这里,我们报道了从喀拉拉邦沿海地区分离的放线菌中分离和鉴定了霉素霉素A。我们首次证明它具有抗分枝杆菌活性。发现它对浮游和细胞内的M具有杀菌作用。肺结核,MIC为3.125μgmL ?1 ;它是非溶血性的,细胞毒性可忽略不计。发现产生金霉素A的放线菌是 Streptomyces sp。通过16S rRNA基因测序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号